CIK 0001773751 · Large accelerated filer
Hims & Hers Health, Inc.
Sign in to watch- Ticker
- HIMS
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 415-851-0195
- Business address
- 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
- Former names
- Oaktree Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,052,782
- in 14 filings, $4.1M under 10b5-1 plans
Net −$4,052,782. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | Cosgrove Delos M. Director | Option exercise · Restricted Stock Unit | −3,656 | 0 | ||
| 2026-05-26 | WELLS DAVID B Director | Purchase | +48,400 | $24.24 | $1.2M | 224,417 |
| 2026-05-20 | Carroll Patrick Harrison Chief Medical Officer | Grant or award · Restricted Stock Unit | +435 | 435 | ||
| 2026-05-20 | Payne Christopher D Director | Grant or award · Restricted Stock Unit | +647 | 647 | ||
| 2026-05-20 | WELLS DAVID B Director | Grant or award · Restricted Stock Unit | +957 | 957 | ||
| 2026-05-18 | Okupe Oluyemi Chief Financial Officer | Option exercise 10b5-1 | +7,950 | $5.01 | $40K | 270,904 |
| 2026-05-18 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −7,950 | $23.64 | $188K | 262,954 |
| 2026-05-18 | Okupe Oluyemi Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −7,950 | 115,900 | ||
| 2026-04-20 | Okupe Oluyemi Chief Financial Officer | Option exercise 10b5-1 | +5,553 | $5.01 | $28K | 275,599 |
| 2026-04-20 | Okupe Oluyemi Chief Financial Officer | Option exercise 10b5-1 | +7,000 | $11.53 | $81K | 282,599 |
| 2026-04-20 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −19,645 | $29.96 | $589K | 262,954 |
| 2026-04-20 | Okupe Oluyemi Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,553 | 123,850 | ||
| 2026-04-20 | Okupe Oluyemi Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −7,000 | 35,996 | ||
| 2026-04-20 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −9,463 | $30.00 | $284K | 299,368 |
| 2026-04-17 | Okupe Oluyemi Chief Financial Officer | Option exercise 10b5-1 | +6,184 | $5.01 | $31K | 288,051 |
| 2026-04-17 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −18,005 | $27.83 | $501K | 270,046 |
| 2026-04-17 | Okupe Oluyemi Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −6,184 | 129,403 | ||
| 2026-04-16 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −36,922 | $25.90 | $956K | 281,867 |
| 2026-04-09 | Dudum Andrew Chief Executive Officer | Gift | −422,933 | 887,684 | ||
| 2026-04-09 | Dudum Andrew Chief Executive Officer | Gift | +422,933 | 470,457 |
Page 10 of 15 · 296 trades